Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	THSD4 RELN SSPOP FBN1 HMCN2 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 CHADL VWA1 MMRN1 MUC6	8.50e-10	188	202	15	GO:0005201
GeneOntologyMolecularFunction	tyrosinase activity	TYR TYRP1	1.02e-04	2	202	2	GO:0004503
GeneOntologyMolecularFunction	collagen binding	MAP1A COL6A1 NID2 VWF CHADL CSPG4	1.72e-04	81	202	6	GO:0005518
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	AXL LTBP4 ALK NTRK3 EFNA4 EPHA1	2.24e-04	85	202	6	GO:0019199
GeneOntologyMolecularFunction	structural constituent of synapse-associated extracellular matrix	LAMB1 LAMB2	3.03e-04	3	202	2	GO:0150043
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	AXL ALK NTRK3 EFNA4 EPHA1	5.09e-04	65	202	5	GO:0004714
GeneOntologyBiologicalProcess	neuron projection development	RELN MAP1A TPRN CSMD3 ADAM10 PRAG1 ADCY1 KANK1 HMCN2 AMIGO3 NTM UCN ALK KIF13B DIP2B LRP12 FAT4 SZT2 NTRK3 LAMB1 LAMB2 REG1A LPAR1 TFAP4 EFNA4 TENM3 CSPG4 SLIT1 LGR6 INPP5J	1.13e-05	1285	205	30	GO:0031175
GeneOntologyCellularComponent	extracellular matrix	THSD4 RELN ADAM10 SSPOP F12 SVEP1 WNT5B FBN1 HMCN2 LTBP4 COL6A1 NID2 INHBE VWF LAMB1 LAMB2 REG1A CHADL VWA1 ANGPTL1 MMRN1 MST1 CLEC14A CSPG4 LGR6 BCAM MUC6	4.45e-10	656	208	27	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	THSD4 RELN ADAM10 SSPOP F12 SVEP1 WNT5B FBN1 HMCN2 LTBP4 COL6A1 NID2 INHBE VWF LAMB1 LAMB2 REG1A CHADL VWA1 ANGPTL1 MMRN1 MST1 CLEC14A CSPG4 LGR6 BCAM MUC6	4.76e-10	658	208	27	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	THSD4 RELN ADAM10 SSPOP F12 WNT5B FBN1 HMCN2 LTBP4 COL6A1 NID2 INHBE VWF LAMB1 LAMB2 REG1A CHADL VWA1 ANGPTL1 MMRN1 MST1 CLEC14A CSPG4 BCAM	6.81e-10	530	208	24	GO:0062023
GeneOntologyCellularComponent	basement membrane	FBN1 HMCN2 COL6A1 NID2 LAMB1 LAMB2 VWA1	2.22e-04	122	208	7	GO:0005604
GeneOntologyCellularComponent	microfibril	THSD4 FBN1 LTBP4	2.58e-04	13	208	3	GO:0001527
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMB1 LAMB2 MMRN1	5.96e-04	17	208	3	GO:0098637
Domain	EGF_2	RELN SSPOP F12 SVEP1 FBN1 HMCN2 BTC C6 LTBP4 NID2 FAT4 LAMB1 LAMB2 MMRN1 TENM3 CLEC14A SLIT1 EPHA1	9.15e-10	265	206	18	PS01186
Domain	EGF-like_CS	RELN F12 SVEP1 FBN1 HMCN2 BTC C6 LTBP4 NID2 FAT4 LAMB1 LAMB2 MMRN1 TENM3 CLEC14A SLIT1 EPHA1	5.15e-09	261	206	17	IPR013032
Domain	EGF-like_dom	RELN F12 SVEP1 FBN1 HMCN2 BTC C6 LTBP4 NID2 FAT4 LAMB1 LAMB2 MMRN1 TENM3 CLEC14A SLIT1	1.79e-08	249	206	16	IPR000742
Domain	EGF_1	RELN SSPOP F12 SVEP1 FBN1 HMCN2 BTC C6 LTBP4 FAT4 LAMB1 LAMB2 MMRN1 TENM3 CLEC14A SLIT1	2.50e-08	255	206	16	PS00022
Domain	EGF_3	RELN SSPOP F12 SVEP1 FBN1 HMCN2 BTC C6 LTBP4 NID2 FAT4 MMRN1 TENM3 CLEC14A SLIT1	5.54e-08	235	206	15	PS50026
Domain	EGF	RELN F12 SVEP1 FBN1 BTC LTBP4 NID2 FAT4 LAMB1 LAMB2 MMRN1 TENM3 CLEC14A SLIT1	3.62e-07	235	206	14	SM00181
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 MMRN1 CLEC14A SLIT1	2.64e-06	106	206	9	IPR000152
Domain	EGF_CA	F12 SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 MMRN1 SLIT1	8.44e-06	122	206	9	SM00179
Domain	Growth_fac_rcpt_	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 LAMB1 LAMB2 SLIT1 EPHA1	9.28e-06	156	206	10	IPR009030
Domain	EGF-like_Ca-bd_dom	F12 SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 MMRN1 SLIT1	9.63e-06	124	206	9	IPR001881
Domain	EGF_Ca-bd_CS	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 SLIT1	9.95e-05	97	206	7	IPR018097
Domain	EGF_CA	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 SLIT1	1.13e-04	99	206	7	PS01187
Domain	ASX_HYDROXYL	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4 CLEC14A	1.21e-04	100	206	7	PS00010
Domain	Cys_knot_C	SSPOP VWF SLIT1 MUC6	1.52e-04	25	206	4	IPR006207
Domain	CTCK_2	SSPOP VWF SLIT1 MUC6	1.52e-04	25	206	4	PS01225
Domain	ig	FCRL2 AXL NTM LILRB3 LILRA3 NTRK3 MYOM3 LILRA6 BCAM	2.67e-04	190	206	9	PF00047
Domain	Immunoglobulin	FCRL2 AXL NTM LILRB3 LILRA3 NTRK3 MYOM3 LILRA6 BCAM	2.67e-04	190	206	9	IPR013151
Domain	C8	SSPOP VWF MUC6	2.70e-04	12	206	3	PF08742
Domain	TIL	SSPOP VWF MUC6	2.70e-04	12	206	3	PF01826
Domain	Inhibin_asu	INHBB GDF2 INHBE	3.49e-04	13	206	3	IPR002405
Domain	Unchr_dom_Cys-rich	SSPOP VWF MUC6	3.49e-04	13	206	3	IPR014853
Domain	C8	SSPOP VWF MUC6	3.49e-04	13	206	3	SM00832
Domain	-	TYR TYRP1	3.61e-04	3	206	2	1.10.1280.10
Domain	Unchr_di-copper_centre	TYR TYRP1	3.61e-04	3	206	2	IPR008922
Domain	Laminin_IV_B	LAMB1 LAMB2	3.61e-04	3	206	2	IPR013015
Domain	TYROSINASE_1	TYR TYRP1	3.61e-04	3	206	2	PS00497
Domain	TYROSINASE_2	TYR TYRP1	3.61e-04	3	206	2	PS00498
Domain	LAMININ_IVB	LAMB1 LAMB2	3.61e-04	3	206	2	PS51116
Domain	Tyrosinase	TYR TYRP1	3.61e-04	3	206	2	PF00264
Domain	Tyrosinase_Cu-bd	TYR TYRP1	3.61e-04	3	206	2	IPR002227
Domain	EGF_CA	SVEP1 FBN1 HMCN2 LTBP4 NID2 FAT4	3.78e-04	86	206	6	PF07645
Domain	TIL_dom	SSPOP VWF MUC6	4.40e-04	14	206	3	IPR002919
Domain	ZF_PHD_2	NSD1 KMT2D ASXL3 KDM7A KDM4B RAI1	6.44e-04	95	206	6	PS50016
Domain	VWF_type-D	SSPOP VWF MUC6	6.66e-04	16	206	3	IPR001846
Domain	VWFD	SSPOP VWF MUC6	6.66e-04	16	206	3	PS51233
Domain	VWD	SSPOP VWF MUC6	6.66e-04	16	206	3	SM00216
Domain	VWD	SSPOP VWF MUC6	6.66e-04	16	206	3	PF00094
Domain	ZF_PHD_1	NSD1 KMT2D ASXL3 KDM7A KDM4B RAI1	6.81e-04	96	206	6	PS01359
Domain	G2F	HMCN2 NID2	7.16e-04	4	206	2	PF07474
Domain	NIDOGEN_G2	HMCN2 NID2	7.16e-04	4	206	2	PS50993
Domain	GFP	HMCN2 NID2	7.16e-04	4	206	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 NID2	7.16e-04	4	206	2	IPR006605
Domain	PROTEIN_KINASE_TYR	AXL PRAG1 ALK NTRK3 AATK EPHA1	7.19e-04	97	206	6	PS00109
Domain	Tyr_kinase_AS	AXL PRAG1 ALK NTRK3 AATK EPHA1	7.19e-04	97	206	6	IPR008266
Domain	CTCK_1	SSPOP VWF SLIT1	9.55e-04	18	206	3	PS01185
Domain	VWC_out	SSPOP VWF MUC6	1.12e-03	19	206	3	SM00215
Domain	YD	NID2 TENM3	1.18e-03	5	206	2	IPR006530
Domain	DMAP_binding	DIP2B DIP2C	1.18e-03	5	206	2	PF06464
Domain	KH_dom_type_1	MEX3C KHNYN PCBP1 PCBP2	1.38e-03	44	206	4	IPR004088
Domain	EPHD	KMT2D KDM4B RAI1	1.74e-03	22	206	3	PS51805
Domain	CT	VWF SLIT1 MUC6	1.74e-03	22	206	3	SM00041
Domain	DMAP1-bd	DIP2B DIP2C	1.76e-03	6	206	2	IPR010506
Domain	A1B_glyco/leuk_Ig-like_rcpt	LILRA3 LILRA6	1.76e-03	6	206	2	IPR016332
Domain	DMAP_binding	DIP2B DIP2C	1.76e-03	6	206	2	SM01137
Domain	LDLRA_1	SSPOP C6 ALK LRP12	1.91e-03	48	206	4	PS01209
Domain	LDrepeatLR_classA_rpt	SSPOP C6 ALK LRP12	2.07e-03	49	206	4	IPR002172
Domain	LDLa	SSPOP C6 ALK LRP12	2.07e-03	49	206	4	SM00192
Domain	LDLRA_2	SSPOP C6 ALK LRP12	2.07e-03	49	206	4	PS50068
Domain	VWFA	SVEP1 HMCN2 COL6A1 VWF VWA1	2.13e-03	82	206	5	PS50234
Domain	Ig-like_fold	FCRL2 AXL CAMTA2 IL22RA1 HMCN2 AMIGO3 NTM LILRB3 LILRA3 NTRK3 MYOM3 LILRA6 VWA1 CSF3R BCAM IL4R EPHA1	2.18e-03	706	206	17	IPR013783
Domain	VWA	SVEP1 HMCN2 COL6A1 VWF VWA1	2.37e-03	84	206	5	SM00327
Domain	TB	FBN1 LTBP4	2.45e-03	7	206	2	PF00683
Domain	Ephrin_rec_like	SVEP1 TG EPHA1	2.54e-03	25	206	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	SVEP1 TG EPHA1	2.54e-03	25	206	3	IPR011641
Domain	Sushi	CSMD2 CSMD3 SVEP1 C6	2.57e-03	52	206	4	PF00084
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	RELN ADAM10 SSPOP FBN1 HMCN2 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 REG1A VWA1 MMRN1	4.55e-12	175	212	14	28071719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 PRAG1 PLEKHG1 SEC16A PLA2G6 LTBP4 CRAMP1 PKN3 PRRC2B SZT2 KHNYN MYOM3 NSD1 LAMB2 MLXIP C2CD3 KMT2D AATK RPAP1 NAPRT CSPG4 DIP2C PDCD11 TANC1 BCAM IL4R RAI1 AHNAK2	2.14e-10	1105	212	28	35748872
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	ADAM10 FBN1 HMCN2 LTBP4 COL6A1 VWF LAMB1 LAMB2 VWA1 MMRN1 CLEC14A CSPG4	5.52e-10	167	212	12	22159717
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	FBN1 HMCN2 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 VWA1 CSPG4 BCAM	1.77e-09	146	212	11	27068509
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	THSD4 F12 FBN1 LTBP4 COL6A1 INHBE VWF LAMB1 LAMB2 VWA1 MST1	2.91e-09	153	212	11	25037231
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	SSPOP NAXE COL6A1 NID2 LAMB1 LAMB2 CHADL	1.31e-07	64	212	7	22261194
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	FBN1 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 MMRN1 CSPG4	1.58e-07	135	212	9	28675934
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	INHBB ADAM10 SVEP1 FBN1 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 CPXM1	4.12e-07	248	212	11	24006456
Pubmed	Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family.	TYR TYRP1 PMEL	8.89e-07	4	212	3	8432998
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 PRAG1 MEX3C PLEKHG1 SYNE2 SEC16A HELZ NR3C2 KIF13B DIP2B MAP7D3 NTRK3 MLXIP NUAK2 C2CD3 TANC1 USP54 MAP3K21 AHNAK2	1.61e-06	861	212	19	36931259
Pubmed	Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.	TYR TYRP1 PMEL	2.21e-06	5	212	3	7479744
Pubmed	Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.	SLC24A5 TYR TYRP1	2.21e-06	5	212	3	19060277
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	FBN1 LTBP4 COL6A1 NID2 LAMB1 LAMB2 BCAM	2.29e-06	97	212	7	27559042
Pubmed	SLC45A2: a novel malignant melanoma-associated gene.	TYR TYRP1 PMEL	4.41e-06	6	212	3	18563784
Pubmed	Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells.	LAMB1 LAMB2 BCAM	4.41e-06	6	212	3	16236823
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	KANK1 BUB1 SEC16A HELZ MAP7D3 KHNYN UPF1 MAP4K5 FAM222B TANC1 USP54	5.19e-06	322	212	11	39098523
Pubmed	Interaction of major coat color gene functions in mice as studied by chemical analysis of eumelanin and pheomelanin.	TYR TYRP1 PMEL	7.68e-06	7	212	3	11277491
Pubmed	Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type.	TYR TYRP1 PMEL	7.68e-06	7	212	3	18463683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CAMTA2 CSMD3 PLEKHG1 KANK1 SYT11 SEC16A PRRC2B KHNYN MLXIP RPAP1 TENM3 SLIT1	8.61e-06	407	212	12	12693553
Pubmed	Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.	SLC24A5 TYR TYRP1	1.22e-05	8	212	3	19384953
Pubmed	Bridging expressed sequence alignments through targeted cDNA sequencing.	CARMIL3 DIP2B SZT2	1.22e-05	8	212	3	15028280
Pubmed	Altered melanocyte differentiation and retinal pigmented epithelium transdifferentiation induced by Mash1 expression in pigment cell precursors.	TYR TYRP1 PMEL	1.22e-05	8	212	3	16185282
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SPATA31E1 MAP1A RAD54L2 ZNF469 ARHGAP31 BUB1 TCOF1 MAGEE1 USF3 AATK MAP4K5 MDC1	1.49e-05	430	212	12	35044719
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF142 TTLL5 SYNE2 DIP2B AATK TANC1	1.60e-05	87	212	6	12465718
Pubmed	Chemical characterization of hair melanins in various coat-color mutants of mice.	TYR TYRP1 PMEL	1.83e-05	9	212	3	7665913
Pubmed	Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.	TYR TYRP1 PMEL	1.83e-05	9	212	3	24769727
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A TTLL5 FBN1 ARHGAP31 SEC16A MAP7D3 C2CD3 KMT2D	1.86e-05	184	212	8	32908313
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ACD RAD54L2 SSPOP LTBP4 PRRC2B BEGAIN FAT4 HTRA2 LAMB1 MAGEE1 SLIT1 USP54 PCBP1 PCBP2	2.48e-05	608	212	14	16713569
Pubmed	Oculocutaneous Albinism and Ocular Albinism Overview	SLC24A5 TYR TYRP1	2.60e-05	10	212	3	37053367
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	COL6A1 NID2 LAMB1 LAMB2	2.83e-05	29	212	4	22613833
Pubmed	Rab27a regulates the peripheral distribution of melanosomes in melanocytes.	TYR TYRP1 PMEL	3.55e-05	11	212	3	11266470
Pubmed	Platelet adhesion to multimerin 1 in vitro: influences of platelet membrane receptors, von Willebrand factor and shear.	VWF MMRN1	3.70e-05	2	212	2	19175495
Pubmed	Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains.	PCBP1 PCBP2	3.70e-05	2	212	2	7607214
Pubmed	The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus.	TYR TYRP1	3.70e-05	2	212	2	1706745
Pubmed	αCP Poly(C) binding proteins act as global regulators of alternative polyadenylation.	PCBP1 PCBP2	3.70e-05	2	212	2	23629627
Pubmed	Downregulated INHBB in endometrial tissue of recurrent implantation failure patients impeded decidualization through the ADCY1/cAMP signalling pathway.	INHBB ADCY1	3.70e-05	2	212	2	36913138
Pubmed	Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.	TYR TYRP1	3.70e-05	2	212	2	14634018
Pubmed	Ethnic variation in tyrosinase and TYRP1 expression in photoexposed and photoprotected human skin.	TYR TYRP1	3.70e-05	2	212	2	12519123
Pubmed	Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication.	PCBP1 PCBP2	3.70e-05	2	212	2	12414943
Pubmed	Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.	PCBP1 PCBP2	3.70e-05	2	212	2	30132844
Pubmed	Dual functions of cell-autonomous and non-cell-autonomous ADAM10 activity in granulopoiesis.	ADAM10 CSF3R	3.70e-05	2	212	2	22042698
Pubmed	Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo.	TYR TYRP1	3.70e-05	2	212	2	18042623
Pubmed	The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins.	LAMB1 LAMB2	3.70e-05	2	212	2	19147489
Pubmed	NTM and NR3C2 polymorphisms influencing intelligence: family-based association studies.	NTM NR3C2	3.70e-05	2	212	2	21036197
Pubmed	The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage.	AXL ADAM10	3.70e-05	2	212	2	7822279
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	3.70e-05	2	212	2	33526815
Pubmed	ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.	AXL ALK	3.70e-05	2	212	2	26616860
Pubmed	The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.	HTRA2 CSPG4	3.70e-05	2	212	2	26340347
Pubmed	ADAMTSL6β protein rescues fibrillin-1 microfibril disorder in a Marfan syndrome mouse model through the promotion of fibrillin-1 assembly.	THSD4 FBN1	3.70e-05	2	212	2	21880733
Pubmed	The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.	VWF MMRN1	3.70e-05	2	212	2	27052467
Pubmed	Identification of two KH domain proteins in the alpha-globin mRNP stability complex.	PCBP1 PCBP2	3.70e-05	2	212	2	7556077
Pubmed	Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2.	ADAM10 CSPG4	3.70e-05	2	212	2	25387269
Pubmed	Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome.	LAMB1 LAMB2	3.70e-05	2	212	2	21876163
Pubmed	Immunoglobulin-like receptors and the generation of innate immune memory.	LILRA3 LILRA6	3.70e-05	2	212	2	35034136
Pubmed	αCP binding to a cytosine-rich subset of polypyrimidine tracts drives a novel pathway of cassette exon splicing in the mammalian transcriptome.	PCBP1 PCBP2	3.70e-05	2	212	2	26896798
Pubmed	Molecular interactions within the melanogenic complex: formation of heterodimers of tyrosinase and TRP1 from B16 mouse melanoma.	TYR TYRP1	3.70e-05	2	212	2	9918801
Pubmed	Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.	LILRB3 LILRA6	3.70e-05	2	212	2	36449053
Pubmed	The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.	ADAM10 BTC	3.70e-05	2	212	2	17895248
Pubmed	Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry.	PCBP1 PCBP2	3.70e-05	2	212	2	8855318
Pubmed	WARP interacts with collagen VI-containing microfibrils in the pericellular matrix of human chondrocytes.	COL6A1 VWA1	3.70e-05	2	212	2	23300779
Pubmed	The TYRP1-mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains.	TYR TYRP1	3.70e-05	2	212	2	31077632
Pubmed	Functional analysis of the tyrosinase gene and brown-locus protein gene promoters.	TYR TYRP1	3.70e-05	2	212	2	8433000
Pubmed	Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).	TYR RAI1	3.70e-05	2	212	2	17024248
Pubmed	A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog.	PCBP1 PCBP2	3.70e-05	2	212	2	10455157
Pubmed	Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.	LILRB3 LILRA6	3.70e-05	2	212	2	19617579
Pubmed	Switch in Laminin β2 to Laminin β1 Isoforms During Aging Controls Endothelial Cell Functions-Brief Report.	LAMB1 LAMB2	3.70e-05	2	212	2	29599141
Pubmed	Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy.	COL6A1 LAMB1	3.70e-05	2	212	2	10407855
Pubmed	ADAMTSL-6 is a novel extracellular matrix protein that binds to fibrillin-1 and promotes fibrillin-1 fibril formation.	THSD4 FBN1	3.70e-05	2	212	2	19940141
Pubmed	ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx.	ADAM10 BTC	3.70e-05	2	212	2	15507448
Pubmed	Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.	LILRB3 LILRA6	3.70e-05	2	212	2	24096970
Pubmed	Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression.	PCBP1 PCBP2	3.70e-05	2	212	2	21752917
Pubmed	PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions.	PCBP1 PCBP2	3.70e-05	2	212	2	32647012
Pubmed	Ultraviolet B radiation-stimulated urocortin 1 is involved in tyrosinase-related protein 1 production in human melanoma HMV-II cells.	TYRP1 UCN	3.70e-05	2	212	2	25240771
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SEC16A HELZ FAM135A PRRC2B MAP7D3 KHNYN TANC1 USP54 AHNAK2	3.73e-05	263	212	9	34702444
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	HELZ PRRC2B NID2 TCOF1 LAMB1 UPF1 MDC1 PCBP2	3.76e-05	203	212	8	22083510
Pubmed	Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution.	RELN SSPOP DGLUCY SYNE2 BCAM	5.30e-05	66	212	5	15790807
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCDC1 MAP1A PLCXD1 TPRN ZNF469 HMCN2 TC2N BRDT SEC16A FOXL2NB HELZ LTBP4 PRRC2B NID2 TCOF1 LAMB1 TANC1 USP54 RAI1	5.96e-05	1116	212	19	31753913
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MAP1A TPRN RAD54L2 BUB1 SEC16A HELZ FAM135A PRRC2B KIF13B TCOF1 MST1 TANC1 PCBP2	7.31e-05	588	212	13	38580884
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	ADCY1 MEX3C SYNE2 HELZ TCOF1 LAMB1 UPF1 TENM3 MDC1 SLIT1	7.66e-05	358	212	10	32460013
Pubmed	Platelet storage pool deficiency associated with inherited abnormalities of the inner ear in the mouse pigment mutants muted and mocha.	TYR FBN1 PMEL	7.74e-05	14	212	3	1912584
Pubmed	Comparison of melanoblast expression patterns identifies distinct classes of genes.	TYR TYRP1 PMEL	7.74e-05	14	212	3	19493314
Pubmed	PAX6 regulates melanogenesis in the retinal pigmented epithelium through feed-forward regulatory interactions with MITF.	TYR TYRP1 PMEL	7.74e-05	14	212	3	24875170
Pubmed	Iris phenotypes and pigment dispersion caused by genes influencing pigmentation.	TYR TYRP1 PMEL	9.63e-05	15	212	3	18715234
Pubmed	Laminin alpha5 chain is required for intestinal smooth muscle development.	LAMB1 LAMB2 BCAM	9.63e-05	15	212	3	12921739
Pubmed	Basement membrane composition in the early mouse embryo day 7.	NID2 LAMB1 LAMB2	9.63e-05	15	212	3	15895400
Pubmed	Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.	VWF TG CSPG4	9.63e-05	15	212	3	36305765
Pubmed	Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.	TYR TYRP1 NTM	9.63e-05	15	212	3	23548203
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NUP205 AMIGO3 ARHGAP31 FTO CRAMP1 SZT2 NUAK2 MDC1 PDCD11 KDM7A KDM4B RAI1	1.09e-04	529	212	12	14621295
Pubmed	An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.	ALK NTRK3	1.11e-04	3	212	2	34378283
Pubmed	The interleukin-4 receptor gene (IL4R) maps to 16p11.2-16p12.1 in human and to the distal region of mouse chromosome 7.	TYR IL4R	1.11e-04	3	212	2	1679753
Pubmed	Lrp12/Mig13a reveals changing patterns of preplate neuronal polarity during corticogenesis that are absent in reeler mutant mice.	RELN LRP12	1.11e-04	3	212	2	20439316
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD3	1.11e-04	3	212	2	12906867
Pubmed	Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest.	PCBP1 PCBP2	1.11e-04	3	212	2	19211566
Pubmed	Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1.	TYR TYRP1	1.11e-04	3	212	2	14623273
Pubmed	Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).	LAMB1 LAMB2	1.11e-04	3	212	2	10814726
Pubmed	Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients.	TYR TYRP1	1.11e-04	3	212	2	17200659
Pubmed	Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells.	TYR TYRP1	1.11e-04	3	212	2	24884952
Pubmed	Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes.	TYR TYRP1	1.11e-04	3	212	2	17766092
Pubmed	Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex.	PCBP1 PCBP2	1.11e-04	3	212	2	9234743
Pubmed	ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.	TYR TYRP1	1.11e-04	3	212	2	18488027
Interaction	LILRA6 interactions	LILRB3 LILRA3 LILRA6	4.06e-06	4	204	3	int:LILRA6
Interaction	FBXO2 interactions	THSD4 AXL ADAM10 FBN1 AMIGO3 NTM SYNE2 LTBP4 COL6A1 NID2 FFAR1 LAMB1 LAMB2 TENM3 CSPG4 EPHA1	4.79e-06	411	204	16	int:FBXO2
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	AXL ALK NTRK3 AATK	2.08e-04	40	133	4	321
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	FCRL2 TNFRSF10A ADAM10 ALK LILRB3 LILRA3 LILRA6 CSF3R BCAM IL4R	6.74e-04	394	133	10	471
GeneFamily	CD molecules\|Activating leukocyte immunoglobulin like receptors	LILRA3 LILRA6	7.90e-04	6	133	2	1181
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CSMD3 SVEP1 C6	8.18e-04	57	133	4	1179
Coexpression	NABA_ECM_GLYCOPROTEINS	THSD4 RELN SSPOP SVEP1 FBN1 HMCN2 LTBP4 NID2 VWF LAMB1 LAMB2 VWA1 MMRN1 SLIT1	5.39e-10	191	211	14	MM17059
Coexpression	NABA_CORE_MATRISOME	THSD4 RELN SSPOP SVEP1 FBN1 HMCN2 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 CHADL VWA1 MMRN1 SLIT1	7.07e-10	270	211	16	MM17057
Coexpression	NABA_ECM_GLYCOPROTEINS	THSD4 RELN SSPOP SVEP1 FBN1 HMCN2 LTBP4 NID2 VWF LAMB1 LAMB2 VWA1 MMRN1 SLIT1	7.57e-10	196	211	14	M3008
Coexpression	NABA_CORE_MATRISOME	THSD4 RELN SSPOP SVEP1 FBN1 HMCN2 LTBP4 COL6A1 NID2 VWF LAMB1 LAMB2 CHADL VWA1 MMRN1 SLIT1	9.23e-10	275	211	16	M5884
Coexpression	NABA_MATRISOME	THSD4 RELN INHBB GDF2 ADAM10 SSPOP F12 SVEP1 WNT5B FBN1 HMCN2 BTC LTBP4 COL6A1 NID2 INHBE VWF LAMB1 LAMB2 REG1A CHADL VWA1 ANGPTL1 MMRN1 MST1 CLEC14A CSPG4 SLIT1 MUC6	2.95e-09	1008	211	29	MM17056
Coexpression	NABA_MATRISOME	THSD4 RELN INHBB GDF2 ADAM10 SSPOP F12 SVEP1 WNT5B FBN1 HMCN2 BTC LTBP4 COL6A1 NID2 INHBE VWF LAMB1 LAMB2 REG1A CHADL VWA1 ANGPTL1 MMRN1 MST1 CLEC14A CSPG4 SLIT1 MUC6	4.38e-09	1026	211	29	M5889
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	THSD4 INHBB PLCXD1 C9orf152 TC2N SEC16A NKAIN1 KMT2D DIP2C KDM7A PCBP2 INPP5J KDM4B	1.60e-05	385	211	13	M2840
Coexpression	GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP	PLCXD1 CAMTA2 FBXL18 SYT11 CLIC1 PMEL RPAP1 LGR6 IL4R	3.74e-05	200	211	9	M6780
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	CELF4 MARCHF10 TC2N LTBP4 ANKRD35 MARCHF9 NSD1 VWA1 SLCO5A1 AATK CPXM1 LGR6 IL4R RAI1	5.07e-05	493	211	14	M1951
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	CELF4 MARCHF10 TC2N LTBP4 ANKRD35 MARCHF9 NSD1 VWA1 SLCO5A1 AATK CPXM1 LGR6 IL4R RAI1	6.42e-05	504	211	14	MM830
Coexpression	MARTENS_TRETINOIN_RESPONSE_UP	CELF4 C16orf90 INHBB BIRC7 GDF2 ACTL7B C9orf152 HMCN2 UCN TMC8 GRIN3B COL6A1 MYOM3 TG CLEC14A NAPRT BCAM MUC6 KRT38	6.80e-05	855	211	19	M2098
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 RELN HSPA12B PLEKHG1 NEURL1B PKN3 VWF DUSP6 MMRN1 BCL6B CLEC14A	2.83e-09	196	212	11	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 NTM LTBP4 NID2 FAT4 MAMLD1 LPAR1 TENM3 MAP4K5	2.98e-09	197	212	11	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 NTM LTBP4 NID2 FAT4 MAMLD1 LPAR1 TENM3 MAP4K5	2.98e-09	197	212	11	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HSPA12B ADCY1 SVEP1 FBN1 LTBP4 COL6A1 FAT4 LAMB2 ANGPTL1 LPAR1 CSPG4	3.31e-09	199	212	11	95d95e9b7bd3933188998ae94986213eb0f1e5ea
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1A SVEP1 ZNF469 FBN1 NTM ANKRD35 COL6A1 NID2 FAT4 LAMB1 CPXM1	3.31e-09	199	212	11	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	AXL ADCY1 FBN1 BTC LTBP4 COL6A1 LAMB2 ANGPTL1 LPAR1 CSPG4 AHNAK2	3.49e-09	200	212	11	747c61d4e0b746278ae1f45ca4cd556c6961c76a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	AXL ADCY1 FBN1 BTC LTBP4 COL6A1 LAMB2 ANGPTL1 LPAR1 CSPG4 AHNAK2	3.49e-09	200	212	11	de1d193f773f4e2927baa6fc38d29754b015c6e6
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BIRC7 TYR TYRP1 FBN1 COL6A1 NID2 FAT4 LAMB1 PMEL CSPG4	1.27e-08	175	212	10	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SVEP1 ZNF469 FBN1 HMCN2 LTBP4 COL6A1 LAMB1 LPAR1 CPXM1 AHNAK2	1.75e-08	181	212	10	3462aa1c08fbaf613b6278ab2c7a5a0940bf537d
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SVEP1 ZNF469 FBN1 HMCN2 LTBP4 COL6A1 LAMB1 LPAR1 CPXM1 AHNAK2	1.75e-08	181	212	10	6730e249cac55ae892cc567d9211615882f3dab4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPA12B WNT5B PLEKHG1 FBN1 SYT11 ARHGAP31 PKN3 VWF CLEC14A	2.91e-08	191	212	10	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B WNT5B PLEKHG1 FBN1 ARHGAP31 LTBP4 PKN3 VWF BCL6B CLEC14A	3.21e-08	193	212	10	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPA12B PLEKHG1 HMCN2 SYT11 LTBP4 PKN3 VWF BCL6B CLEC14A	3.72e-08	196	212	10	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	INHBB HSPA12B NEURL1B PKN3 VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	3.90e-08	197	212	10	951f18f326967206adbbfc422cce9eea3d2e0854
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AXL SVEP1 FBN1 NTM FAT4 NTRK3 MAMLD1 LPAR1 TENM3	3.90e-08	197	212	10	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	INHBB HSPA12B NEURL1B PKN3 VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	3.90e-08	197	212	10	7caa2c86dc4d50b57a7db8f7278d1588282ad6db
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AXL SVEP1 FBN1 NTM FAT4 MAMLD1 LPAR1 TENM3 MAP4K5	4.09e-08	198	212	10	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	368C-Endothelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	INHBB HSPA12B NEURL1B PKN3 VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	4.09e-08	198	212	10	9a2c2201baee51581733e183065298a97eba4553
ToppCell	5'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN INHBB PLEKHG1 ARHGAP31 ADGRG3 VWF MMRN1 BCL6B CLEC14A BCAM	4.09e-08	198	212	10	90e85fe7a0ab376a41666dfff6c0e95b7f1c9475
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PLEKHG1 NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.09e-08	198	212	10	72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PLEKHG1 NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.09e-08	198	212	10	e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PLEKHG1 NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.29e-08	199	212	10	9c40b3ee39860e9d8edafd007daec11abdd95435
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PLEKHG1 NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.29e-08	199	212	10	72b34bce8157abe389e95cd3ed8ba578dce0cbf6
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG1 NID2 ENOX1 MAGEE1 LPAR1 NUAK2 SLCO5A1 MST1 USP54	1.02e-07	165	212	9	9d2bdc42c13c8c2a68889bec8612a1ce56f659fa
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 GDF2 IL22RA1 SYNE2 COL6A1 NID2 TENM3 MUC6 AHNAK2	1.14e-07	167	212	9	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 GDF2 IL22RA1 SYNE2 COL6A1 NID2 TENM3 MUC6 AHNAK2	1.14e-07	167	212	9	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4\|TCGA-Lung / Sample_Type by Project: Shred V9	AXL ZNF469 FBN1 COL6A1 NID2 ADGRG3 ENOX1 LAMB1 CPXM1	1.19e-07	168	212	9	aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCell	368C-Endothelial_cells-Endothelial-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	INHBB PLEKHG1 ABCC8 PKN3 VWF VWA1 BCL6B CLEC14A BCAM	1.69e-07	175	212	9	c4088b5f9fa145869cf5dd8bee7680b1c8fada42
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SGSM1 TC2N FBXL18 LRP12 ADGRG3 MARCHF9 SHROOM2 MMRN1	1.69e-07	175	212	9	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	368C-Endothelial_cells-Endothelial-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	INHBB PLEKHG1 ABCC8 PKN3 VWF VWA1 BCL6B CLEC14A BCAM	1.69e-07	175	212	9	ca0d3e3a0a271cccdd3881b055fecb626712478d
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SGSM1 TC2N FBXL18 LRP12 ADGRG3 MARCHF9 SHROOM2 MMRN1	1.69e-07	175	212	9	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TYR TYRP1 FBN1 NTM BEGAIN COL6A1 NID2 NTRK3 PMEL	2.36e-07	182	212	9	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPA12B FBN1 NTM UCN PKN3 FAT4 VWF LAMB2 PKD2L1	2.71e-07	185	212	9	f98af3146ec2f44c30d31a662fb9c4fa3ca4f706
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TYR TYRP1 FBN1 NTM COL6A1 NID2 FAT4 PMEL CSPG4	2.71e-07	185	212	9	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AXL WNT5B FBN1 NTM LTBP4 COL6A1 NTRK3 LPAR1 CPXM1	2.84e-07	186	212	9	c0a036096c2cb23305605b8aaf18869d6e0fb512
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HMCN2 ARHGAP31 NEURL1B PKN3 VWF VWA1 CLEC14A TANC1 BCAM	2.84e-07	186	212	9	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	INHBB AS3MT CLIC1 BTC ALK LGR6 BCAM AHNAK2	3.16e-07	137	212	8	5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 LTBP4 NID2 MAMLD1 LPAR1 TENM3 TANC1	3.25e-07	189	212	9	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 LTBP4 NID2 MAMLD1 LPAR1 TENM3 TANC1	3.25e-07	189	212	9	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 NTM NEURL1B NTRK3 TENM3 CSPG4 LGR6	3.39e-07	190	212	9	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF469 FBN1 NTM LTBP4 COL6A1 ANGPTL1 LPAR1 TENM3 CPXM1	3.55e-07	191	212	9	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 LTBP4 COL6A1 FAT4 NTRK3 ANGPTL1 LPAR1 TENM3 CPXM1	3.55e-07	191	212	9	053b3664f509baa107feaf90730f80ebf9ac8f14
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF469 FBN1 NTM LTBP4 COL6A1 ANGPTL1 LPAR1 TENM3 CPXM1	3.55e-07	191	212	9	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 WNT5B FBN1 HMCN2 LTBP4 COL6A1 NTRK3 ANGPTL1 LPAR1	3.71e-07	192	212	9	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL SVEP1 FBN1 COL6A1 NID2 LAMB1 LAMB2 ANGPTL1 CPXM1	3.71e-07	192	212	9	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	HSPA12B PRAG1 PLEKHG1 ARHGAP31 SYNE2 PKN3 VWF CLEC14A BCAM	3.71e-07	192	212	9	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPA12B PLEKHG1 SYT11 ARHGAP31 PKN3 VWF BCL6B CLEC14A	3.71e-07	192	212	9	56b021c297a21dff357531f21e2464f85186106d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SVEP1 FBN1 NTM LTBP4 NID2 NTRK3 LPAR1 TENM3	3.71e-07	192	212	9	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	SVEP1 WNT5B FBN1 LTBP4 COL6A1 FAT4 NTRK3 ANGPTL1 LPAR1	3.71e-07	192	212	9	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 LTBP4 ANKRD35 COL6A1 ANGPTL1 LPAR1 TENM3 CPXM1 AHNAK2	3.87e-07	193	212	9	051f61156b0e2e95292b2d8377faf3190b50f264
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPA12B PRAG1 PLEKHG1 ARHGAP31 SYNE2 PKN3 VWF MMRN1 CLEC14A	3.87e-07	193	212	9	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPA12B WNT5B PLEKHG1 FBN1 SYT11 ARHGAP31 PKN3 CLEC14A	3.87e-07	193	212	9	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPA12B PLEKHG1 HMCN2 SYT11 LTBP4 PKN3 BCL6B CLEC14A	3.87e-07	193	212	9	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 FBN1 NTM LTBP4 COL6A1 LAMB1 LPAR1 TENM3 ASXL3	3.87e-07	193	212	9	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AXL SVEP1 NEURL1B LTBP4 MAMLD1 LPAR1 TENM3 TANC1	4.04e-07	194	212	9	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 WNT5B FBN1 HMCN2 LTBP4 COL6A1 FAT4 NTRK3 ANGPTL1	4.04e-07	194	212	9	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	AXL SVEP1 FBN1 HMCN2 NTM LTBP4 COL6A1 LAMB1 LPAR1	4.04e-07	194	212	9	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	INHBB HSPA12B PLEKHG1 NID2 VWF LAMB1 MMRN1 BCL6B CLEC14A	4.04e-07	194	212	9	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AXL SVEP1 NEURL1B LTBP4 MAMLD1 LPAR1 TENM3 TANC1	4.04e-07	194	212	9	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	INHBB NEURL1B VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.04e-07	194	212	9	2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	INHBB NEURL1B VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.04e-07	194	212	9	b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	INHBB HSPA12B PLEKHG1 NID2 VWF LAMB1 MMRN1 BCL6B CLEC14A	4.04e-07	194	212	9	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CAMTA2 NTM LAMB2 AATK RPAP1 CLEC14A PDCD11 TANC1 BCAM	4.04e-07	194	212	9	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CAMTA2 NTM LAMB2 AATK RPAP1 CLEC14A PDCD11 TANC1 BCAM	4.04e-07	194	212	9	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B WNT5B PLEKHG1 FBN1 ARHGAP31 PKN3 FAT4 VWF CLEC14A	4.04e-07	194	212	9	b0c15e7e4bcf30856fb628dedd7ba82df33489f5
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MAP1A AXL ZNF469 FBN1 NTM COL6A1 NID2 TENM3 CPXM1	4.04e-07	194	212	9	55b97095a7a17a312c616703d291738a0f806339
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL SVEP1 FBN1 LTBP4 COL6A1 LAMB1 LAMB2 LPAR1 CPXM1	4.22e-07	195	212	9	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AXL SVEP1 FBN1 NEURL1B LTBP4 NTRK3 LPAR1 TENM3	4.22e-07	195	212	9	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B WNT5B PLEKHG1 FBN1 ARHGAP31 PKN3 VWF BCL6B CLEC14A	4.22e-07	195	212	9	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PKN3 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.22e-07	195	212	9	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPA12B PRAG1 PLEKHG1 ARHGAP31 SYNE2 PKN3 VWF MMRN1 CLEC14A	4.22e-07	195	212	9	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL SVEP1 FBN1 LTBP4 COL6A1 LAMB1 LAMB2 LPAR1 CPXM1	4.22e-07	195	212	9	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL SVEP1 FBN1 LTBP4 COL6A1 LAMB1 LAMB2 LPAR1 CPXM1	4.22e-07	195	212	9	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL FBN1 LTBP4 COL6A1 NID2 LAMB1 LAMB2 LPAR1 CPXM1	4.41e-07	196	212	9	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL FBN1 LTBP4 COL6A1 NID2 LAMB1 LAMB2 LPAR1 CPXM1	4.41e-07	196	212	9	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 NTM LTBP4 COL6A1 LAMB1 LPAR1 TENM3 IL4R	4.60e-07	197	212	9	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.60e-07	197	212	9	9244f087ba4b60fdc81d54ce91860de715b3e12c
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	HSPA12B PRAG1 PLEKHG1 ARHGAP31 SYNE2 PKN3 VWF MMRN1 CLEC14A	4.60e-07	197	212	9	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.80e-07	198	212	9	218f33e068eb126458ec33176de3cfa6fc06ddf0
ToppCell	Tracheal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HSPA12B PLEKHG1 ARHGAP31 NEURL1B ADGRG3 VWF MMRN1 BCL6B CLEC14A	4.80e-07	198	212	9	77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B NID2 VWF LAMB1 VWA1 MMRN1 BCL6B CLEC14A BCAM	4.80e-07	198	212	9	7cddd474416651088a4e08edfc0ac420ff10a5fe
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 FBN1 NTM COL6A1 FAT4 ENOX1 LAMB1 LPAR1 TENM3	4.80e-07	198	212	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	(6)_Endothelial-A_(Artery)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	INHBB HSPA12B PLEKHG1 NEURL1B VWF VWA1 MMRN1 BCL6B CLEC14A	4.80e-07	198	212	9	44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 ARHGAP31 NEURL1B VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	5.01e-07	199	212	9	d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN INHBB NTM LTBP4 NID2 TENM3 PDZK1IP1 CPXM1 BCAM	5.01e-07	199	212	9	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 NTM LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3	5.01e-07	199	212	9	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3 IL4R	5.01e-07	199	212	9	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 NTM LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3	5.01e-07	199	212	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3 IL4R	5.01e-07	199	212	9	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN INHBB NTM LTBP4 NID2 TENM3 PDZK1IP1 CPXM1 BCAM	5.01e-07	199	212	9	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 NTM COL6A1 NID2 LAMB1 LPAR1 TENM3 IL4R	5.01e-07	199	212	9	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	INHBB PLEKHG1 NEURL1B VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	5.01e-07	199	212	9	c2d85f80037f209a4a329790f475d9f98f590262
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 NTM LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3	5.01e-07	199	212	9	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	SVEP1 FBN1 LTBP4 COL6A1 FAT4 ENOX1 LAMB1 LPAR1 TENM3	5.01e-07	199	212	9	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 LTBP4 PKN3 FAT4 VWF MYOM3 LAMB1 CLEC14A BCAM	5.01e-07	199	212	9	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPA12B PLEKHG1 NID2 VWF LAMB1 VWA1 BCL6B CLEC14A BCAM	5.01e-07	199	212	9	463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	SVEP1 FBN1 LTBP4 COL6A1 NID2 LAMB1 LPAR1 TENM3 IL4R	5.01e-07	199	212	9	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)\|367C / Donor, Lineage, Cell class and subclass (all cells)	INHBB PLEKHG1 NEURL1B VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	5.01e-07	199	212	9	29ed081bd5204a32068b420f2244f3704891547b
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 ARHGAP31 NEURL1B VWF VWA1 MMRN1 BCL6B CLEC14A BCAM	5.22e-07	200	212	9	9f889f7ff0b3ba2750aa757b94680a9f7014fd0d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HSPA12B ADCY1 FBN1 NTM LTBP4 COL6A1 FAT4 LAMB1 ANGPTL1	5.22e-07	200	212	9	76f3043cb88071256ff661885fe5a82a54f5b733
Drug	Isothiuronium	TYR TYRP1 PMEL	7.63e-07	3	209	3	ctd:D007550
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	THSD4 ADCY1 BUB1 COL6A1 LRP12 SZT2 DUSP6 GREB1 BCAM INPP5J KDM4B	2.32e-06	198	209	11	6777_UP
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TTLL5 RAD54L2 SVEP1 PLA2G6 DNMT3A LRP12 SZT2 TFAP4 GREB1 INPP5J AHNAK2	2.32e-06	198	209	11	6037_DN
Drug	lamtidine	TYR TYRP1 PMEL	3.03e-06	4	209	3	CID000071988
Drug	dihydroxyindole	TYR TYRP1 PMEL	1.49e-05	6	209	3	CID000021860
Drug	NSC-105306	TYR TYRP1 PMEL	1.49e-05	6	209	3	CID000266586
Disease	cutaneous melanoma, hair color	SLC24A5 TYR TYRP1 SYNE2 FTO DNMT3A	5.05e-06	62	208	6	EFO_0000389, EFO_0003924
Disease	Albinism, Oculocutaneous	SLC24A5 TYR TYRP1	1.18e-05	7	208	3	C0078918
Disease	Malignant neoplasm of breast	PPP1R12B ADAM10 CLIC1 SYNE2 MROH7 KLHDC7A FTO ALK DNMT3A NID2 INHBE VWF MAGEE1 SHROOM2 LPAR1 MST1 KMT2D DIP2C UQCC1 LGR6 USP54	2.61e-05	1074	208	21	C0006142
Disease	FEV/FEC ratio	THSD4 HIVEP2 GALK2 KANK1 FBN1 BRDT ARHGAP31 GID4 BTC NTM SYNE2 FTO LTBP4 NID2 ENOX1 NSD1 TFAP4 TG SLCO5A1 RPAP1 CSPG4 KDM7A	6.13e-05	1228	208	22	EFO_0004713
Disease	oculocutaneous albinism (is_implicated_in)	TYR TYRP1	2.94e-04	4	208	2	DOID:0050632 (is_implicated_in)
Disease	superoxide dismutase [Mn]; mitochondrial measurement	F12 NSD1	2.94e-04	4	208	2	EFO_0021981
Disease	melanoma	TYR TYRP1 FTO ALK FAT4 PMEL KDM4B RAI1	3.99e-04	248	208	8	C0025202
Disease	retinal drusen	SVEP1 PLEKHG1 C12orf42 VWF	4.63e-04	51	208	4	EFO_1001155
Disease	nevus count, cutaneous melanoma	TYR TYRP1 SYNE2 PLA2G6 FTO	4.72e-04	91	208	5	EFO_0000389, EFO_0004632
Disease	pulmonary arterial hypertension	SLC24A5 FBN1 C12orf42	4.82e-04	22	208	3	EFO_0001361
Disease	palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement	PKD2L1 MAP4K5	4.88e-04	5	208	2	EFO_0800504
Disease	serum urea measurement	DCDC1 NKAIN1 FTO NSD1 MAP4K5 CSPG4 LGR6	4.88e-04	195	208	7	EFO_0009795
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	CAMTA2 SYNE2	7.28e-04	6	208	2	EFO_0800611
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	7.28e-04	6	208	2	EFO_0802705
Disease	Malformation of cortical development	RELN LAMB1	7.28e-04	6	208	2	cv:C1955869
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	7.28e-04	6	208	2	EFO_0801767
Disease	Lissencephaly	RELN LAMB1	7.28e-04	6	208	2	cv:C0266463
Disease	neurotic disorder	CELF4 MMRN1 AATK TENM3 ASXL3	7.59e-04	101	208	5	EFO_0004257
Disease	glucose tolerance test	ABCC8 CLEC14A MAP4K5	8.91e-04	27	208	3	EFO_0004307
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	DGLUCY LRP12 NSD1 LAMB1 UQCC1	9.05e-04	105	208	5	EFO_0007788, EFO_0008007, EFO_0008343
Disease	palmitoleic acid measurement	PKD2L1 MAP4K5	1.01e-03	7	208	2	EFO_0007973
Disease	Oculocutaneous albinism	TYR TYRP1	1.01e-03	7	208	2	cv:C0078918
Disease	osteoarthritis	RELN DCDC1 CSMD3 PRAG1 NKAIN1 FTO UQCC1	1.05e-03	222	208	7	MONDO_0005178
Disease	corneal topography	ZNF469 FBN1 NR3C2 COL6A1 LPAR1	1.07e-03	109	208	5	EFO_0004345
Disease	Depressive disorder	RELN CSMD2 UCN NR3C2 FTO ALK DUSP6 TG	1.08e-03	289	208	8	C0011581
Disease	amino acid measurement	DCDC1 WNT5B NR3C2 ALK FAT4 VWF ENOX1 LAMB1 MLXIP MMRN1 MAP4K5 SLIT1 BCAM	1.12e-03	678	208	13	EFO_0005134
Disease	myelodysplastic syndrome (is_implicated_in)	MEFV DNMT3A CSF3R	1.22e-03	30	208	3	DOID:0050908 (is_implicated_in)
Disease	Mammary Carcinoma, Human	PPP1R12B ADAM10 CLIC1 KLHDC7A FTO ALK DNMT3A LPAR1 MST1 KMT2D LGR6	1.33e-03	525	208	11	C4704874
Disease	Mammary Neoplasms, Human	PPP1R12B ADAM10 CLIC1 KLHDC7A FTO ALK DNMT3A LPAR1 MST1 KMT2D LGR6	1.33e-03	525	208	11	C1257931
Disease	opioid-binding protein/cell adhesion molecule measurement	NTM MAP4K5	1.35e-03	8	208	2	EFO_0020618
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 VWF	1.35e-03	8	208	2	DOID:4783 (biomarker_via_orthology)
Disease	diastolic blood pressure, self reported educational attainment	PIK3C2G SLIT1	1.35e-03	8	208	2	EFO_0004784, EFO_0006336
Disease	Mammary Neoplasms	PPP1R12B ADAM10 CLIC1 KLHDC7A FTO ALK DNMT3A LPAR1 MST1 KMT2D LGR6	1.37e-03	527	208	11	C1458155
Disease	type 2 diabetes mellitus (is_implicated_in)	AXL PIK3C2G BTC ABCC8 FTO FFAR1	1.38e-03	171	208	6	DOID:9352 (is_implicated_in)
Disease	breast size	INHBB BTC FTO MAP4K5	1.45e-03	69	208	4	EFO_0004884
Disease	pulse pressure measurement, alcohol drinking	AS3MT FBN1 FTO C1orf167	1.53e-03	70	208	4	EFO_0004329, EFO_0005763
Disease	cutaneous squamous cell carcinoma	TYR TYRP1 SEC16A	1.61e-03	33	208	3	EFO_1001927
Disease	Breast Carcinoma	PPP1R12B ADAM10 CLIC1 KLHDC7A FTO ALK DNMT3A LPAR1 MST1 KMT2D LGR6	1.61e-03	538	208	11	C0678222
Disease	central corneal thickness	ZNF469 FBN1 NR3C2 COL6A1 LPAR1 TFAP4 MST1 CPXM1	1.65e-03	309	208	8	EFO_0005213
Disease	cutaneous melanoma	TYR TYRP1 SYNE2 PLA2G6 FTO	1.70e-03	121	208	5	EFO_0000389
Disease	margarate 17:0 measurement	ALK PKD2L1	1.72e-03	9	208	2	EFO_0021066
Disease	level of Sterol ester (27:1/16:1) in blood serum	PKD2L1 MAP4K5	1.72e-03	9	208	2	OBA_2045190
Disease	leucine measurement	DCDC1 PRAG1 NTM MAP4K5	1.79e-03	73	208	4	EFO_0009770
Disease	triacylglycerol 52:5 measurement	TG TENM3 MAP4K5	1.91e-03	35	208	3	EFO_0010417
Disease	puberty onset measurement	SPEM3 INHBB FTO TFAP4 MAP4K5	1.96e-03	125	208	5	EFO_0005677
Disease	melanoma	TYR HMCN2 PLA2G6 FTO UQCC1	2.03e-03	126	208	5	EFO_0000756
Disease	Growth Disorders	DNMT3A LPAR1 RAI1	2.08e-03	36	208	3	C0018273
Disease	aortic measurement	THSD4 DCDC1 TMEM170A FBN1 ABCC8 LTBP4 LPAR1	2.11e-03	251	208	7	EFO_0020865
Disease	response to corticosteroid, age at assessment	THSD4 HIVEP2	2.14e-03	10	208	2	EFO_0008007, GO_0031960
Disease	hair colour measurement, eye colour measurement, skin pigmentation measurement	SLC24A5 TYR	2.14e-03	10	208	2	EFO_0007009, EFO_0007822, EFO_0009764
Disease	1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement	PKD2L1 MAP4K5	2.14e-03	10	208	2	EFO_0800464
Disease	Sarcomatoid Renal Cell Carcinoma	BIRC7 CSMD3 SYNE2 ALK IL4R	2.18e-03	128	208	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	BIRC7 CSMD3 SYNE2 ALK IL4R	2.18e-03	128	208	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	BIRC7 CSMD3 SYNE2 ALK IL4R	2.18e-03	128	208	5	C1266044
Disease	systolic blood pressure, alcohol drinking	AS3MT PLEKHG1 FBN1 FTO C1orf167	2.18e-03	128	208	5	EFO_0004329, EFO_0006335
Disease	Papillary Renal Cell Carcinoma	BIRC7 CSMD3 SYNE2 ALK IL4R	2.18e-03	128	208	5	C1306837
Disease	Renal Cell Carcinoma	BIRC7 CSMD3 SYNE2 ALK IL4R	2.18e-03	128	208	5	C0007134
Disease	Mental Depression	RELN CSMD2 UCN NR3C2 FTO ALK DUSP6	2.25e-03	254	208	7	C0011570
Disease	Drugs used in diabetes use measurement	HIVEP2 ABCC8 FTO NSD1 RPAP1 CLEC14A MAP4K5	2.30e-03	255	208	7	EFO_0009924
Disease	cystatin C measurement	HIVEP2 DCDC1 F12 FTO NSD1 RPAP1 MAP4K5 CSPG4 TANC1	2.32e-03	402	208	9	EFO_0004617
Disease	erythrocyte measurement	ZNF142 AS3MT DIP2B TRIM58 NUAK2 PDZK1IP1 FAM222B	2.41e-03	257	208	7	EFO_0005047
Disease	cortical thickness	THSD4 RELN GALK2 DCDC1 AS3MT TMEM170A ADAM10 PLEKHG1 ZNF469 FBN1 FOXL2NB DIP2B LPAR1 TFAP4 TG UQCC1 KDM4B	2.42e-03	1113	208	17	EFO_0004840
Disease	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA	AXL DUSP6	2.61e-03	11	208	2	146110
Disease	pigmentation disease (is_implicated_in)	TYR TYRP1	2.61e-03	11	208	2	DOID:10123 (is_implicated_in)
Disease	Hypogonadotropic hypogonadism 7 with or without anosmia	AXL DUSP6	2.61e-03	11	208	2	cv:C0342384
Disease	level of Ceramide (d40:1) in blood serum	SYNE2 MAP4K5	2.61e-03	11	208	2	OBA_2045185
Disease	Neoplasm Recurrence, Local	LTBP4 ALK DNMT3A	2.62e-03	39	208	3	C0027643
Disease	factor VIII measurement	F12 TC2N VWF	2.81e-03	40	208	3	EFO_0004630
Disease	skin pigmentation measurement	SLC24A5 TYR TYRP1 FBN1 SLCO5A1	2.92e-03	137	208	5	EFO_0007009
Disease	acute myeloid leukemia (is_implicated_in)	MEFV DNMT3A NSD1 CSF3R	2.98e-03	84	208	4	DOID:9119 (is_implicated_in)
Disease	chronic musculoskeletal pain	AMIGO3 GMPPB	3.12e-03	12	208	2	EFO_0022195
Disease	Congenital muscular dystrophy	GMPPB COL6A1	3.12e-03	12	208	2	cv:C0699743
Disease	ascending aortic diameter	THSD4 DCDC1 FBN1 ABCC8 LPAR1	3.21e-03	140	208	5	EFO_0021787
Disease	obsolete_red blood cell distribution width	AS3MT WNT5B PLEKHG1 SYNE2 TMC8 PLA2G6 NEURL1B GRIN3B FTO DIP2B INHBE TRIM58 ASAH2 KHNYN PKD2L1 TSPAN32 PDZK1IP1 MAP4K5 FAM222B	3.29e-03	1347	208	19	EFO_0005192
Disease	cholesteryl esters to total lipids in small HDL percentage	ADAM10 MAP4K5 BCAM	3.46e-03	43	208	3	EFO_0022254
Disease	tRNA (guanine-N(7)-)-methyltransferase measurement	F12 MAP4K5	3.66e-03	13	208	2	EFO_0802162
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	PKD2L1 MAP4K5	3.66e-03	13	208	2	OBA_2045082
Disease	Anxiety States, Neurotic	UCN TG RAI1	3.70e-03	44	208	3	C0376280
Disease	Anxiety neurosis (finding)	UCN TG RAI1	3.70e-03	44	208	3	C1279420
Disease	Anxiety Disorders	UCN TG RAI1	3.70e-03	44	208	3	C0003469
Disease	lymphocyte count	ZNF469 KANSL2 FBN1 FBXL18 SYT11 ARHGAP31 HELZ PLA2G6 NR3C2 NEURL1B DNMT3A INHBE TRIM58 NSD1 PKD2L1 LPAR1 RAB36 MAP4K5 KDM4B RAI1	3.70e-03	1464	208	20	EFO_0004587
Disease	eye color	SLC24A5 NUP205 TYR TYRP1	3.82e-03	90	208	4	EFO_0003949
Disease	Gastric Adenocarcinoma	AXL BRDT NTRK3	3.94e-03	45	208	3	C0278701
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	BIRC7 CSMD3 SYNE2 ALK IL4R	4.06e-03	148	208	5	C0279702
Disease	receptive language perception, parental genotype effect measurement	PLEKHG1 ENOX1	4.26e-03	14	208	2	EFO_0005686, EFO_0005939
Disease	lysophosphatidylcholine 16:1 measurement	PKD2L1 MAP4K5	4.26e-03	14	208	2	EFO_0010358
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	SPATS1 FAT4	4.26e-03	14	208	2	EFO_0004670, EFO_0006794
Disease	urate measurement, bone density	THSD4 MEX3C C9orf152 NTM SEC16A NR3C2 FTO FAM135A PRRC2B TG MAP4K5	4.69e-03	619	208	11	EFO_0003923, EFO_0004531
Disease	rectum cancer, overall survival	BTC DIP2C	4.89e-03	15	208	2	EFO_0000638, EFO_1000657
Disease	triacylglycerol 52:3 measurement	PKD2L1 MAP4K5	4.89e-03	15	208	2	EFO_0010415
Disease	osteoarthritis, knee	DCDC1 PRAG1 FTO CHADL UQCC1	5.35e-03	158	208	5	EFO_0004616
Disease	sexual dimorphism measurement	ZNF142 HIVEP2 RAD54L2 HROB FBN1 SEC16A FTO DNMT3A DIP2B MARCHF9 NSD1 MLXIP LPAR1 FER1L4 SLIT1 UQCC1	5.40e-03	1106	208	16	EFO_0021796
Disease	status epilepticus (biomarker_via_orthology)	RELN ADAM10 ABCC8 HTRA2	5.55e-03	100	208	4	DOID:1824 (biomarker_via_orthology)
Disease	pro-hydroxy-pro measurement	NR3C2 ALK	5.56e-03	16	208	2	EFO_0021132
Disease	T-Cell Lymphoma	KMT2D ASXL3	5.56e-03	16	208	2	C0079772
Disease	serum gamma-glutamyl transferase measurement	THSD4 C16orf90 SGSM1 MAP1A AXL TNFRSF10A HSPA12B CSMD3 SYT11 KLHDC7A PKN3 MAP4K5 MUC6 EPHA1	5.60e-03	914	208	14	EFO_0004532
Disease	Endometrioma	FBN1 NR3C2 NTRK3 LAMB1 GREB1	5.79e-03	161	208	5	C0269102
Disease	Endometriosis	FBN1 NR3C2 NTRK3 LAMB1 GREB1	5.79e-03	161	208	5	C0014175
Disease	body surface area	FBN1 C12orf42 PLA2G6 FTO DNMT3A COL6A1 NSD1 TFAP4 AATK MAP4K5 SLIT1	6.19e-03	643	208	11	EFO_0022196
Disease	IGF-1 measurement, IGFBP-3 measurement	ADCY1 MAP4K5	6.27e-03	17	208	2	EFO_0004626, EFO_0004627

Protein segments in the cluster

Peptide	Gene	Start	Entry
RGPSSGSCIDQLPIK	SYT11	111	Q9BT88
GRCSLINTPSPLVTG	nan	51	Q9HAA7
AGQLLSPETVGCPLS	PABPN1L	121	A6NDY0
QVACTGPPSAPRNLS	EPHA1	326	P21709
QEPLARPSSCLRQSG	C1orf167	346	Q5SNV9
TQPGLPELTAACLGR	ACTL7B	311	Q9Y614
GPSVGSQQELRAPCL	BUB1	326	O43683
ISCGNPGTPSNARVV	CSMD2	2891	Q7Z408
VTCPTPPQISNGRLE	CSMD3	3231	Q7Z407
GSQTLTVCPGSVQPL	CSPG4	1586	Q6UVK1
GGSPCNDLSIVNPAR	DNMT3A	706	Q9Y6K1
KNECIPPEGRTGVTQ	BRDT	691	Q58F21
VQLCGTASSPEPEQG	BEGAIN	526	Q9BUH8
GRTITLQPGSPCNDF	ADAM10	621	O14672
IPGGTCDLNSQPRST	FAT4	3661	Q6V0I7
LSCAPKTRPQNGSII	CAMTA2	61	O94983
RSTLGRPQCTGLTPS	CD300LD-AS1	186	Q96MU5
RPQCTGLTPSLAGES	CD300LD-AS1	191	Q96MU5
QETGCPPLGLESLRV	CPXM1	111	Q96SM3
TQERCGPRSLGSPVL	BIRC7	26	Q96CA5
QEKPTEGPRNTCLGS	ADGRG3	21	Q86Y34
PEQRITGPICVNTKG	ANGPTL1	56	O95841
QLRGSLSPCREPGTS	ANKRD35	756	Q8N283
LGEDGQQPPRCTSTT	RAD54L2	61	Q9Y4B4
SCTGLGLQDVPAELP	AMIGO3	46	Q86WK7
TGVIIVNPNCRSPSN	ASXL3	1156	Q9C0F0
TQQGTGIPEAAQLPC	C9orf152	166	Q5JTZ5
TESLGAGQPVPVECR	POLM	106	Q9NP87
DSQGRLCPASNPILS	MROH7	116	Q68CQ1
TITRCSQPLVGPNDK	MTMR1	301	Q13613
LPTSGADPLCRNPTN	RAI1	1391	Q7Z5J4
RAQTPIVCTSLSPGG	NSD1	106	Q96L73
LQEKGCGARTPSPSL	RBMX2	131	Q9Y388
GRAEPQLSQPSLDCG	RAB36	51	O95755
NENCSLPLVLGSAPG	PIK3C2G	686	O75747
GCDTLDISVPPGSRN	GDF2	236	Q9UK05
SRPQTQGEDCSLPVG	NOBOX	176	O60393
TPCPQALGRQPSSAL	NOBOX	631	O60393
STTNLQDPGVLGCPR	NUP205	1016	Q92621
PTPTSPGVCSVREQQ	MUC6	2341	Q6W4X9
GPDISPGRKTQCTEI	DCDC1	956	M0R2J8
EGNCPERIITLTGPT	PCBP1	51	Q15365
QKPGLLGRTCQEVPS	PAQR7	196	Q86WK9
QGIPIVCPVSRSSNE	KDM7A	486	Q6ZMT4
RSPPTVLVICGPGNN	NAXE	106	Q8NCW5
ACGETPEQIRAPSGI	LRP12	46	Q9Y561
QGTPLTCSPNVENRG	NR3C2	231	P08235
PLNGNILSCSPDRRS	MAP1A	2076	P78559
DCGSLNGTQILRPPK	MDC1	91	Q14676
PQGPSDSQILQGLCA	MAGEE1	46	Q9HCI5
SVNISLSGCQPAPEG	GEMIN2	81	O14893
PTPQPDCSLRTGQRS	GREB1	1196	Q4ZG55
NNISLTCIATGRPEP	NTM	151	Q9P121
NAVITCNGSGSPLPD	NTRK3	226	Q16288
LISCQQPGAPRLEGS	LGR6	901	Q9HBX8
TGGSCPQRSQKISNP	MMRN1	241	Q13201
NKSPRGTLCPTGEQR	FAM27B	36	Q5VT28
SRAAAGCLNQVPLSP	FOXL2NB	116	Q6ZUU3
LTPVSRILIGNPGCT	FTO	91	Q9C0B1
IVGQPLELPCQASGS	HMCN2	1731	Q8NDA2
GDVSPNILGPRCINT	ASAH2	351	Q9NR71
RGLNPGTVNSCCIPT	INHBB	361	P09529
RNVSVSPIDIGCQPG	KRT38	21	O76015
PELCSVQLARNGAGP	FER1L4	1621	A9Z1Z3
VDPSARIGQNCSIGP	GMPPB	256	Q9Y5P6
LCCQRSENPTGPTEG	LPAR1	326	Q92633
TQLRTLSDPPGCPGQ	CARMIL3	861	Q8ND23
AVQTLQPPRTATGLG	FAM90A27P	321	A6NNH2
DCRPLEGNSTVTGQP	INHBE	191	P58166
TVQGQGPCNSERLFP	FAM135A	791	Q9P2D6
LLTAVPPASCQQGLG	PDZK1IP1	11	Q13113
SVCEGQIANPSPISR	FAM222B	286	Q8WU58
PTPESSGQCLRLQVS	EFNA4	136	P52798
NCLVDGNIPPSSGLS	GALK2	131	Q01415
NVAICLQGTSGPDPT	DIP2B	1321	Q9P265
VPCPEPRTTSGQQGI	KANK1	71	Q14678
CGPPQLTVGLTASRR	KANK1	781	Q14678
ITSRDCVQLGPPSEG	KDM4B	966	O94953
PRGIETPQCDQSTGQ	LAMB1	1136	P07942
RLTASSTCGLNGPQP	LAMB2	61	P55268
RVVDLSGSCQKGPVP	HROB	201	Q8N3J3
QGPVLAPGQSLTLQC	LILRA6	231	Q6PI73
QGPVLAPGQSLTLQC	LILRB3	231	O75022
RDGGKNTAPLTICPV	MEFV	761	O15553
RTQESCGIAPLTPSQ	HSPA12B	31	Q96MM6
IPCNGSSRTAQPREL	HELZ	1816	P42694
EQCPGPGSRCTNIIA	PLCXD1	286	Q9NUJ7
RICFQGPEQGELLSP	MARCHF9	111	Q86YJ5
VLSTCRAPDQPGEGV	RELN	781	P78509
EGNCPERIITLAGPT	PCBP2	51	Q15366
TQLRTGRPCSQVPGS	GID4	11	Q8IVV7
VQGTRSQPGTTPACI	NID2	1071	Q14112
SCQQLLPATGVPVTR	MLXIP	796	Q9HAP2
ARQGNGPVLVCAPSN	UPF1	521	Q92900
SSGGQRTALPTLPCE	ADCY1	711	Q08828
CLTSGTPGPRAQLTA	HTRA2	71	O43464
SNSLSQSPCPRELGP	IL4R	501	P24394
SLVGERSSGQPCPQA	BCL6B	211	Q8N143
LPRQGSPSQSLVACE	C2CD3	2141	Q4AC94
TSLGINTPVNGSPVC	FFAR1	156	O14842
CPNNGRPTLSGTECL	C6	526	P13671
RDTTPLNVLCSPGIQ	COL6A1	736	P12109
RPESALACGGNLSPQ	DSCR9	121	P59020
ISPDLCGRGQCVNTP	FBN1	1076	P35555
GENCTLTPLPGVARV	CRAMP1	401	Q96RY5
VNLAICLQGTSGPDP	DIP2C	1301	Q9Y2E4
DLQTNGCVTTARPVP	AS3MT	26	Q9HBK9
PQGTLGPRNSLCSAL	C16orf90	106	A8MZG2
RPSGQAGAILPLCNT	CSF3R	376	Q99062
QVSLGRQPPSCQALG	MAMLD1	696	Q13495
ICQIAGGSPSNPLLE	MARCHF10	661	Q8NA82
PENACGLPSPISTNR	MAP7D3	501	Q8IWC1
GECASPLPGLRTQEV	LTBP4	296	Q8N2S1
IQPPLGRVCGSSQAA	EFHB	126	Q8N7U6
QPLGICTDRTSDPNV	IL22RA1	466	Q8N6P7
TNPGPVGETLLCQLS	KANSL2	106	Q9H9L4
TPASAPQVRLDLGNC	KLHDC7A	421	Q5VTJ3
LLGAQCQGVRAPPSD	KHNYN	216	O15037
SAGNRGPRPLEQVTC	CPSF4	231	O95639
GGPVSLKCETRLSPQ	FCRL2	121	Q96LA5
CQVNTGPLPLLGQSE	DGLUCY	56	Q7Z3D6
TQCLGVPGQRSPLND	MST1	11	P26927
TGLNLRVGATCATPP	CHADL	691	Q6NUI6
TRSPETNGLLCGDPE	BTC	36	P35070
TVQLLCRGDGSPSPE	BCAM	286	P50895
TLGLSSPCDNRVPAQ	DUSP6	346	Q16828
DVSPNLTGVCVNPGI	DYNAP	71	Q8N1N2
GLPGQQLVSDSICVP	ENOX1	61	Q8TC92
TRAQTGPTATGCLPL	FTH1P19	146	P0C7X4
QGSPVTLRCQGSLET	LILRA3	41	Q8N6C8
PQILRRQSSPSCGPV	MAP4K5	426	Q9Y4K4
LGCEQLLTAVPGRSP	PKN3	286	Q6P5Z2
QTELPQARISCPEGT	REG1A	26	P05451
SLTRGLCQALVPPGV	GRIN3B	86	O60391
EQPPSLTRNGPLSCG	F12	346	P00748
AVEPVTGAPNGSRCQ	FUT5	51	Q11128
TADQPGLIPRLCSGL	KIF13B	116	Q9NQT8
PGPEISLTDVCQLRG	SZT2	1411	Q5T011
GPDTQTRQQPCPGLL	SSPOP	4296	A2VEC9
PGQLVQDGRCVPISS	SSPOP	4711	A2VEC9
GPECSLRPNQTEEGT	SYNE2	4191	Q8WXH0
SVCDLRTNKLPGSPG	TC2N	156	Q8N9U0
VIPATQCLTPGIRTN	TCOF1	1006	Q13428
GLPSTGQPSEQVCLR	AATK	1026	Q6ZMQ8
SQLAQTACVVGRPGP	MAP3K21	966	Q5TCX8
PRVGNGTLCPNSTSL	TMEM170A	26	Q8WVE7
NAARPQCPVGLSTLA	PELI3	326	Q8N2H9
IRNSLPPCSRAQSVG	FBXL18	506	Q96ME1
PGCPLQQSLQFERGT	PRORY	131	Q9H606
GLSCSPNLPGQTTVQ	MEX3C	316	Q5U5Q3
LCQGGNSTATLEPPA	SLCO5A1	236	Q9H2Y9
NGISRIQSCIPSPGQ	SLAIN1	441	Q8ND83
SPPQVRGLSSCDQKL	SHROOM2	456	Q13796
APPNQGGLATCSDVR	TANC1	1641	Q9C0D5
QLCQDPRLIPGAGAT	CCT8L2	401	Q96SF2
CGPPSRLQASGDLLQ	SPATA31E1	641	Q6ZUB1
NGPGCLVTPVLNSRL	NKAIN1	111	Q4KMZ8
VSLGTGRSPQVPVTC	PLA2G6	691	O60733
PPLRGCVSVDNLTGL	NUAK2	566	Q9H093
SCPIGENSPLLSGQQ	PMEL	646	P40967
CATPPQLANGVTEGL	SVEP1	2891	Q4LDE5
CRGLTGPLQSLVPSA	ABCC8	656	Q09428
ILSSLGPCQRTQGPE	ACD	236	Q96AP0
EGSCTVPPNVATGRL	ALK	1536	Q9UM73
LSPGERVQCPLPSTQ	AHNAK2	4896	Q8IVF2
ESRGGSSCLRQPPSQ	CELF4	136	Q9BZC1
RTETVQKLCPGGQLP	CLIC1	51	O00299
SPPGTEVSALCRGQL	CLEC14A	206	Q86T13
PSTAIGLCRRSQTPG	C12orf42	216	Q96LP6
ALQTPQCSPGGLTVT	TXN2	31	Q99757
QSTGPGRCLSPNLQA	INPP5J	376	Q15735
VPAGRNCTTLQGLAP	VWA1	381	Q6PCB0
QPGRPLTRLSCQNLG	PDCD11	351	Q14690
PNTCNFSIRGPRLQG	SCLY	356	Q96I15
TLCNSTEDGPIRRNP	TYRP1	301	P17643
TLNLTLQCPGSRQSP	TMC8	146	Q8IU68
ERGLQPTLTNPGECR	VWF	2341	P04275
GSLCQALLPGPSNEA	SEC16A	421	O15027
QEAGILRSPCLTQSP	SPEM3	766	A0A1B0GUW6
LTGNSPRGCRLPSIS	SPATS1	6	Q496A3
PQEPSLLRCSQGGPT	TSPAN32	246	Q96QS1
PTSQPRGNIVGCRIQ	SPIN3	41	Q5JUX0
GITSCDPGVLRPNEL	NEURL1B	341	A8MQ27
QSLCNGTPEGPLRRN	TYR	286	P14679
TGTLRCQLQVQGEPP	AXL	51	P30530
ICSLQSLRPPAGQAG	TROAP	686	Q12815
IIGAQPVCSQLPGLS	WNT5B	41	Q9H1J7
LPRATGNSTQCVISP	SLC24A5	36	Q71RS6
GTGCRSEDQNCVPPL	PRRC2B	716	Q5JSZ5
DVPTTQCIDPQCGGR	TENM3	576	Q9P273
IGIGTSVVTCPQQPS	NAPRT	376	Q6XQN6
GQNPTLLSPLGAEVC	PPP1R3F	701	Q6ZSY5
PALRQTEVQCGSQPS	USF3	1411	Q68DE3
PTGNGIPSRDSENTC	USF3	1801	Q68DE3
IRSPTQTVSPGLLCG	ARHGAP31	1376	Q2M1Z3
IVSPDLPCDAGQGLT	SGSM1	576	Q2NKQ1
CSRLIPVSPTQGQGD	UQCC1	21	Q9NVA1
ETPTPRNQGCQLPGS	RPAP1	186	Q9BWH6
EGQPEARACSGLLQP	UBE2Q2L	11	H0YL09
TNGVAISDPSRCPQP	PRAG1	601	Q86YV5
RVCTISSTGPLQPQP	PKD2L1	36	Q9P0L9
VTVQSPGEAQCLLGP	TNFRSF10A	326	O00220
LGTGTEPPSQRRTCQ	ZNF469	1571	Q96JG9
GTLPCSVPASQQLLR	nan	151	Q6ZR54
RPGCVAELQPRGSNT	TPRN	486	Q4KMQ1
LCLVQTERSGPGETP	ZNF544	311	Q6NX49
SLQTSDPLPGSVQRC	PLEKHG1	1131	Q9ULL1
LSNRGILGPVQSPCP	ZNF142	31	P52746
VSSLPLEGCGNNRPA	THSD4	826	Q6ZMP0
CRPQLQPGSPSLVSE	HIVEP2	761	P31629
RQRPTIGLFTQCSGP	SLIT1	231	O75093
GSLTARSLQIPQCPT	TG	1061	P01266
GGLCSLANIPLTPET	TFAP4	26	Q01664
LVQLCPGSSQRSPEA	UCN	16	P55089
GVCQDTLPRKGETTP	TRIM58	361	Q8NG06
AQNIPSPTGLPRCRS	TTLL5	951	Q6EMB2
GIQAPCRGSPLLVTD	HSD52	61	Q0P140
NSSCSKLPPQEGRGI	USP54	1006	Q70EL1
SGSPRLQETPQDCSG	KMT2D	46	O14686
LQETPQDCSGGPVRR	KMT2D	51	O14686
PGTQTSPLQGLLGCQ	KMT2D	4246	O14686
GAPGSPLNVRCLDVN	MYOM3	371	Q5VTT5
CVITNRPLPSTANGV	PPP1R12B	581	O60237